PMID- 32047576 OWN - NLM STAT- MEDLINE DCOM- 20200921 LR - 20200921 IS - 1942-0994 (Electronic) IS - 1942-0900 (Print) IS - 1942-0994 (Linking) VI - 2020 DP - 2020 TI - Nitrative Stress-Related Autophagic Insufficiency Participates in Hyperhomocysteinemia-Induced Renal Aging. PG - 4252047 LID - 10.1155/2020/4252047 [doi] LID - 4252047 AB - The kidneys are important organs that are susceptible to aging. Hyperhomocysteinemia (HHcy) is a risk factor for nephropathy and is associated with chronic nephritis, purpuric nephritis, and nephrotic syndrome. Numerous studies have shown that elevated serum homocysteine levels can damage the kidneys; however, the underlying mechanism of HHcy on kidney damage remains unclear. In this study, we make use of a diet-induced HHcy rat model and in vitro cell culture to explore the role of autophagy in HHcy-induced renal aging and further explored the underlying mechanism. We demonstrated that HHcy led to the development of renal aging. Promoted kidney aging and autophagic insufficiency were involved in HHcy-induced renal aging. HHcy decreased the expression of transcription factor EB (TFEB), the key transcription factor of autophagy-related genes in renal tissue. Further experiments showed that nitrative stress levels were increased in the kidney of HHcy rats. Interestingly, pretreatment with the peroxynitrite (ONOO(-)) scavenger FeTMPyP not only reduced the Hcy-induced nitrative stress in vitro but also partially attenuated the decrease in TFEB in both protein and mRNA levels. Moreover, our results indicated that HHcy reduced TFEB expression and inhibited TFEB-mediated autophagy activation by elevating nitrative stress. In conclusion, this study showed an important role of autophagic insufficiency in HHcy-induced renal aging, in which downregulation of TFEB plays a major role. Furthermore, downexpression of TFEB was associated with increased nitrative stress in HHcy. This study provides a novel insight into the mechanism and therapeutic strategy for renal aging. CI - Copyright (c) 2020 Shangyue Zhang et al. FAU - Zhang, Shangyue AU - Zhang S AUID- ORCID: 0000-0002-6741-3577 AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Zhang, Yuerong AU - Zhang Y AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Zhang, Xinyu AU - Zhang X AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Luo, Chenghua AU - Luo C AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Cao, Yan AU - Cao Y AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Ji, Dengyu AU - Ji D AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Yan, Wenjing AU - Yan W AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Xue, Ke AU - Xue K AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Chai, Jiayin AU - Chai J AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. FAU - Dai, Hongyan AU - Dai H AUID- ORCID: 0000-0001-6088-9532 AD - Department of Cardiology, Qingdao Municipal Hospital, Qingdao, Shandong, China. FAU - Wang, Wen AU - Wang W AUID- ORCID: 0000-0003-4120-0773 AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. AD - Beijing Key Laboratory of Metabolic Disorders Related Cardiovascular Diseases, Capital Medical University, Beijing, China. LA - eng PT - Journal Article DEP - 20200125 PL - United States TA - Oxid Med Cell Longev JT - Oxidative medicine and cellular longevity JID - 101479826 RN - 0 (5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III)) RN - 0 (Metalloporphyrins) RN - 0LVT1QZ0BA (Homocysteine) RN - 14691-52-2 (Peroxynitrous Acid) SB - IM MH - Aging/*physiology MH - Animals MH - Autophagy MH - Cells, Cultured MH - Homocysteine/*metabolism MH - Humans MH - Hyperhomocysteinemia/*metabolism MH - Kidney/*physiology MH - Kidney Diseases/*metabolism MH - Male MH - Metalloporphyrins MH - Peroxynitrous Acid/metabolism MH - Rats MH - Rats, Sprague-Dawley PMC - PMC7007752 COIS- The authors declare that they have no conflicts of interest. EDAT- 2020/02/13 06:00 MHDA- 2020/09/22 06:00 PMCR- 2020/01/25 CRDT- 2020/02/13 06:00 PHST- 2019/10/10 00:00 [received] PHST- 2019/12/25 00:00 [revised] PHST- 2020/01/10 00:00 [accepted] PHST- 2020/02/13 06:00 [entrez] PHST- 2020/02/13 06:00 [pubmed] PHST- 2020/09/22 06:00 [medline] PHST- 2020/01/25 00:00 [pmc-release] AID - 10.1155/2020/4252047 [doi] PST - epublish SO - Oxid Med Cell Longev. 2020 Jan 25;2020:4252047. doi: 10.1155/2020/4252047. eCollection 2020.